VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-76 Cr | ₹-7.21 Cr | ₹-51 Cr | ₹-17 Cr | ₹56 Cr |
What is the latest Cash Flow from Investing Activities ratio of VENUS REMEDIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-76 Cr |
| Mar2024 | ₹-7.21 Cr |
| Mar2023 | ₹-51 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹56 Cr |
How is Cash Flow from Investing Activities of VENUS REMEDIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-76 Cr | Negative | |
| Mar2024 | ₹-7.21 Cr | Negative | |
| Mar2023 | ₹-51 Cr | Negative | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹56 Cr | - | |
Compare Cash Flow from Investing Activities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,008.9 Cr | 8.9% | 69.8% | 143.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,343.0 Cr | -0.7% | 7.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,774.0 Cr | -0.1% | -4.8% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,665.0 Cr | 2.2% | 6.3% | 11.4% | Stock Analytics | |
| CIPLA | ₹122,878.0 Cr | -0.6% | 1.2% | NA | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,581.0 Cr | 1.5% | 6.4% | 4.8% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 8.9% |
69.8% |
143.5% |
| SENSEX | -0.5% |
1.5% |
6.9% |
You may also like the below Video Courses